Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer

Documenti analoghi

• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational-signatures
  di: Davies, Helen, et al.
  Pubblicazione: (2017)
• Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival
  di: Liu, Jingwei, et al.
  Pubblicazione: (2020)
• A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer
  di: Liu, Zijian, et al.
  Pubblicazione: (2020)
• Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
  di: Kovac, Michal, et al.
  Pubblicazione: (2015)
• BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer
  di: Liu, Ying L., et al.
  Pubblicazione: (2020)